PMSNF Stock UPDATES Proteome Sciences Pl (PMSNF) 0.4710 10/23/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Proteome Sciences Pl (PMSNF) 0.4710 $PMSNF

Major Molecular Diagnostic Product Suppliers by Country 2014: Sales and Market Shares Analysis
M2 - Mon Oct 06, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mbs9pk/sales_and_market) has announced the addition of the "Sales and Market Shares of Major Molecular Diagnostic Product Suppliers by Country" report to their offering. This unique report provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Cepheid - Decode - Diadexus - Eiken - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio For more information visit http://www.researchandmarkets.com/research/mb...and_market
MYGN: 38.36 (+0.76), DHR: 77.52 (+1.95), SQNM: 3.18 (+0.14), CPHD: 49.10 (+1.44), HOLX: 24.78 (+0.47)

UK Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Mon Oct 06, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lgmvkt/uk_sales_and) has announced the addition of the "UK Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides UK sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio For more information visit http://www.researchandmarkets.com/research/lg..._sales_and
MYGN: 38.36 (+0.76), A: 53.89 (+0.84), DHR: 77.52 (+1.95), SQNM: 3.18 (+0.14), HOLX: 24.78 (+0.47)

Italy Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Mon Oct 06, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zw7xts/italy_sales_and) has announced the addition of the "Italy Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Italy sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio For more information visit http://www.researchandmarkets.com/research/zw..._sales_and
MYGN: 38.36 (+0.76), A: 53.89 (+0.84), DHR: 77.52 (+1.95), SQNM: 3.18 (+0.14), HOLX: 24.78 (+0.47)

Germany Major Molecular Diagnostic Product Suppliers Report 2014 - Sales and Market Shares Analysis
M2 - Mon Oct 06, 6:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d86mxx/germany_sales_and) has announced the addition of the "Germany Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Germany sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Cepheid - Diadexus - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Siemens - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/d8..._sales_and
MYGN: 38.36 (+0.76), A: 53.89 (+0.84), DHR: 77.52 (+1.95), CPHD: 49.10 (+1.44), HOLX: 24.78 (+0.47)

Japan Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Fri Oct 03, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zglr3w/japan_sales_and) has announced the addition of the "Japan Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Japan sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/zg..._sales_and
SQNM: 3.18 (+0.14), A: 53.89 (+0.84), DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47)

Germany Major Blood Typing Sales and Market Shares 2014: Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Thu Oct 02, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9z7kkm/germany_sales_and) has announced the addition of the "Germany Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides Germany sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies List of Tables - Germany, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - Germany, HIV-1/2 Blood Screening Market, Reagent Sales by Major Supplier - Germany, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - Germany, HIV/Hepatitis NAT Market, Reagent Sales by Major Supplier - Germany, CMV Blood Screening Market, Reagent Sales by Major Supplier For more information visit http://www.researchandmarkets.com/research/9z..._sales_and
DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

Italy Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Thu Oct 02, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/p6s8wm/italy_sales_and) has announced the addition of the "Italy Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides Italy sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies LIST OF TABLES - Italy, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - Italy, AIDS/Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - Italy, HIV/Hepatitis NAT Market, Reagent Sales by Major Supplier - Italy, CMV Blood Screening Market, Reagent Sales By Major Supplier For more information visit http://www.researchandmarkets.com/research/p6..._sales_and
DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

2014 Japan Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Thu Oct 02, 5:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qwnjr3/japan_sales_and) has announced the addition of the "Japan Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides Japan sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. List of Tables - Japan, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - Japan, HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier - Japan, Hepatitis C Blood Screening Market, Reagent Sales by Major Supplier - Japan, CMV Blood Screening Market, Reagent Sales by Major Supplier - Japan, Syphilis Blood Screening Market, Reagent Sales by Major Supplier Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/qw..._sales_and
DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

2014 France Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Thu Oct 02, 5:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hxmhbj/france_sales_and) has announced the addition of the "France Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides France sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. LIST OF TABLES - France, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - France, HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier - France, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - France, HIV/Hepatitis NAT Screening Market Reagent Sales by Major Supplier - France, CMV Blood Screening Market, Reagent Sales By Major Supplier - France, Syphilis Blood Screening Market, Reagent Sales By Major Supplier Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/hx..._sales_and
DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

2014 Spain Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Thu Oct 02, 5:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/853snl/spain_sales_and) has announced the addition of the "Spain Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides Spain sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. List of Tables - Spain, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - Spain, HIV-1/2 Blood Screening Market, Reagent Sales by Major Supplier - Spain, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - Spain, HIV/Hepatitis NAT Market, Reagent Sales by Major Supplier - Spain, CMV Blood Screening Market, Reagent Sales by Major Supplier - Spain, Syphilis Blood Screening Market, Reagent Sales by Major Supplier Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/85..._sales_and
DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

2014 Global Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test and Country
M2 - Wed Sep 24, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9s9q5g/sales_and_market) has announced the addition of the "Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test and Country" report to their offering. This unique report provides sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies For more information visit http://www.researchandmarkets.com/research/9s...and_market
DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

UK Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test 2014
M2 - Wed Sep 24, 5:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9ftrx7/uk_sales_and) has announced the addition of the "UK Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides UK sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies LIST OF TABLES - U.K., Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - U.K., HIV-1/2 Blood Screening Market, Reagent Sales by Major Supplier - U.K., Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - U.K., Syphilis Blood Screening Market, Reagent Sales by Major Supplier For more information visit http://www.researchandmarkets.com/research/9f..._sales_and
DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

Europe Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test and Country
M2 - Tue Sep 23, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/frmkq9/europe_sales_and) has announced the addition of the "Europe Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test and Country" report to their offering. This unique report from the author provides Europe sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies LIST OF TABLES - France, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - France, HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier - France, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - France, HIV/Hepatitis NAT Screening Market Reagent Sales by Major Supplier - France, CMV Blood Screening Market, Reagent Sales By Major Supplier - France, Syphilis Blood Screening Market, Reagent Sales By Major Supplier - Germany, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - Germany, HIV-1/2 Blood Screening Market, Reagent Sales by Major Supplier - Germany, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - Germany, HIV/Hepatitis NAT Market, Reagent Sales by Major Supplier - Germany, CMV Blood Screening Market, Reagent Sales by Major Supplier - Italy, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - Italy, AIDS/Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - Italy, HIV/Hepatitis NAT Market, Reagent Sales by Major Supplier - Italy, CMV Blood Screening Market, Reagent Sales By Major Supplier - Spain, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - Spain, HIV-1/2 Blood Screening Market, Reagent Sales by Major Supplier - Spain, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - Spain, HIV/Hepatitis NAT Market, Reagent Sales by Major Supplier - Spain, CMV Blood Screening Market, Reagent Sales by Major Supplier - Spain, Syphilis Blood Screening Market, Reagent Sales by Major Supplier - U.K., Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - U.K., HIV-1/2 Blood Screening Market, Reagent Sales by Major Supplier - U.K., Hepatitis Blood Screening Market, Reagent Sales by Major Supplier - U.K., Syphilis Blood Screening Market, Reagent Sales by Major Supplier For more information visit http://www.researchandmarkets.com/research/fr..._sales_and
DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

US Sales and Market Shares of Major Blood Typing Report 2014 - Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Tue Sep 23, 8:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rllfsj/us_sales_and) has announced the addition of the "US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report from the author provides US sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Grifols/Novartis - Hologic/Gen-Probe - Immucor - Orchid CellMark - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher/Life Technologies LIST OF TABLES - U.S.A., Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares - U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier - U.S.A., Hepatitis C Blood Screening Market, Reagent Sales By Major Supplier - U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major Supplier - U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier - U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier For more information visit http://www.researchandmarkets.com/research/rl..._sales_and
DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

Future Horizons and Growth Strategies in the European Blood Banking Market 2014
M2 - Fri Sep 05, 3:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8fc9mp/future_horizons) has announced the addition of the "Future Horizons and Growth Strategies in the European Blood Banking Market 2014: Supplier Shares and Country Forecasts" report to their offering. "2014 Opportunities in the European Blood Banking Market" is a new five-country strategic analysis prepared by the author in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. During the next five years, the European blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview VI. France A. Executive Summary VII. Germany A. Executive Summary VIII. Italy A. Executive Summary IX. Spain A. Executive Summary X. U.K. A. Executive Summary XI. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan For more information visit http://www.researchandmarkets.com/research/8f...e_horizons
DGX: 62.89 (+1.68), DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

Proteome Sciences Plc (PRM) - Product Pipeline Analysis
M2 - Fri Jul 11, 3:30AM CDT
Summary

Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018
M2 - Tue Mar 11, 6:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dp8rj/cancertumor) has announced the addition of the "Concise Analysis of the International Cancer/Tumor Profiling Market - Forecasts to 2018" report to their offering. The global tumor profiling market is anticipated to reach $35.03 billion by 2018 growing at a CAGR of 18.50%. The market is divided by geography (North America, Europe, Asia-Pacific, and Rest of the World), applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, and Research Applications), technologies (Next-Generation Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and Microarray) and segments (Genomics, Proteomics, Metabolomics, and Epigenetics). Further, each application, technology, and segment type is broken down by geography, with an exhaustive revenue analysis for the entire forecast period. Of the above mentioned applications, Personalized Medicine is the largest revenue sector and will be the fastest-growing segment. The cancer profiling market is driven mainly by the rising number of cancer cases. Technological advancements to identify the exact cause of the condition are considered as the second major driver. Additionally, demand for safer and cost-effective treatment further drives the market. The rapid growth of the tumor profiling market is attributed to its promising application in personalized cancer therapy; and its extension in early diagnosis, disease prognosis, and research applications will further enhance its market growth. The current approach of cancer profiling in targeted therapy and personalized medicine for cancer has the potential to address the current demands and fill the gaps in the healthcare industry. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Tumor Profiling Technology Landscape 4 Tumor Profiling Research Portfolio 5 Value Chain Analysis 6 Market Landscape Analysis 7 Technology Adoption And Development Potential, By Geography 8 Technology Investment Analysis 9 Competitive Landscape Analysis 10 Patent Analysis 11 Analyst Insights And Recommendations 12 Company Profiles Companies Mentioned: - Agendia Nv - Biotheranostics - Boreal Genomics, Inc - Caris Life Sciences - Genomic Health, Inc - Illumina, Inc - Life Technologies Corporation - Nanostring Technologies - Neogenomics Laboratories - Oncopath Laboratory - Oxford Gene Technology Ltd - Precision Therapeutics, Inc - Proteome Sciences Plc - Rational Therapeutics - Ribomed Biotechnologies For more information visit http://www.researchandmarkets.com/research/9d...ancertumor
ILMN: 189.68 (+4.86), GHDX: 33.13 (+0.42)

2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Blood Culture, Urine Screening and Immunodiagnostics
M2 - Tue Feb 18, 8:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/48jvmv/2014_automated) has announced the addition of the "2014 Automated Microbiology Market -- A Global Strategic Outlook: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics" report to their offering. '2014 Automated Microbiology Market--A Global Strategic Outlook' is a new seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. This comprehensive seven-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Worldwide Market Overview - Estimated universe of laboratories performing microbiology testing by country. - Specimen, test volume and sales forecasts by country. Market Segmentation Analysis - Sales and market shares for major suppliers by individual test and country. - Volume and sales forecasts for over 100 infectious disease assays by individual test and country. - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). - Review of the market dynamics, trends, structure, size, growth and major suppliers by country Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Diamedix - DiaSorin - Eiken Chemical - Enzo Biochem - Exact Sciences - Fujirebio/Innogenetics - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech - Li-Cor Biosciences - Life Technology - Lonza - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Novartis Diagnostics/Grifols - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Sierra Molecular - Shimadzu - Takara Bio - Tecan - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/48..._automated About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MYGN: 38.36 (+0.76), A: 53.89 (+0.84), SI: 132.66 (-1.58), DHR: 77.52 (+1.95), SQNM: 3.18 (+0.14), ENZ: 5.00 (+0.20), CPHD: 49.10 (+1.44), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)

2014 Opportunities in the US Blood Banking Market
M2 - Tue Sep 10, 10:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3n5fm8/2014) has announced the addition of the "2014 Opportunities in the US Blood Banking Market" report to their offering. 2014 Opportunities in the US Blood Banking Market is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. Rationale During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications. Strategic Recommendations - New product development opportunities with significant market appeal. - Alternative market penetration strategies. - Potential market entry barriers and risks. The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years. Key Topics Covered: I. Introduction II. Major Product Development Opportunities III. Alternative Market Penetration Strategies IV. Potential Market Entry Barriers and Risks V. Worldwide Technology and Market Overview B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured C. Major in Vitro Diagnostic Technologies And Their Potential Applications VI. U.S.A. VII. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio/Innogenetics - Hologic/Gen-Probe - Grifols - Immucor - Novartis Diagnostics - Ortho-Clinical Diagnostics - Orchid CellMark - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan VIII. Appendix For more information visit http://www.researchandmarkets.com/research/3n5fm8/2014
SI: 132.66 (-1.58), DGX: 62.89 (+1.68), DHR: 77.52 (+1.95), HOLX: 24.78 (+0.47), NVS: 89.27 (+1.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 84

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 98

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
Tamara Toles O'Laughlin: Steering Philanthropy's Next Era

Updated Category News Views 52

Leadership Transition in Philanthropy Everyone knows the drill: leadership changes are often a toss-up. You could get a fresh burst of energy or spend years longing for the good old days. That's where The New York Women's Foundation finds itself as they hand over the reins from Ana L. Oliveira to Tamara Toles O'Laughlin. In a world where philanthropic shifts can either...

Continue Reading
Fairfax Crest: A New Chapter in Affordable Housing

Updated Category News Views 31

Setting the Stage: Fairfax Crest's Grand Opening You know what's better than leaving a dusty old car park underutilized? Turning it into homes for folks who really need them. That's exactly what went down in Fairfax County as they cut the ribbon on their latest affordable housing project, Fairfax Crest. We're talking 279 affordable units sprouting up where there once lay...

Continue Reading
Hisense's AI S7 Dishwasher Revolutionizes Home Living

Updated Category News Views 75

The Intersection of AI and Home Appliances In a world where families are looking for more efficiency, Hisense isn’t just tossing another dishwasher into the wild. No, they're aiming to redefine the whole damn experience of household chores with their latest brainchild, the Hisense S7 Dishwasher. Packed with AI smarts and an impressive tech bouquet, this bad boy is all...

Continue Reading
Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Updated Category News Views 38

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

Continue Reading
XCMG Climbs Fortune China 500: Strengthens Global Edge

Updated Category News Views 83

XCMG's Ascent on the Fortune China 500 When it comes to scaling new heights, XCMG Machinery is clearly in the driver's seat, roaring up the Fortune China 500 to claim the 202nd spot, leaping ten ranks from last year. While others may coast, XCMG's trajectory is anything but idle, retaining its crown among Chinese construction machinery titans. The recent summit in Chengdu...

Continue Reading
Common Thread Advisors: Transforming Change in Business

Updated Category News Views 41

Navigating the Storm of Change: A New Player in Town You know, just when you think you've got the business world figured out, something sharp comes along. Today, it’s Common Thread Advisors, making its grand entrance to help organizations steer through the dense fog of change. This isn’t your everyday, run-of-the-mill consultancy. No sir, they’re out here with a...

Continue Reading
Bybit’s Gold Yield Offer: 2.83% APR on XAUT

Updated Category News Views 74

Gold Savings with a Tokenized Twist Taking a wild swing at pairing gold and crypto in a digestible package, Bybit and the XAUE Protocol have teamed up to offer a 2.83% fixed APR on XAUT Savings. If you're itching for something that doesn’t make your stomach churn like some of the wild crypto rides, this just might soothe those nerves. Or maybe it’s just a slick way to...

Continue Reading
Fluence Faces Legal Battle Amid Major Stock Plunge

Updated Category News Views 55

The High Stakes for Fluence Energy Investors Well, here's a plot twist, or perhaps not for those who've been keeping an eye on the renewable energy sector. Fluence Energy (NASDAQ:FLNC), a supposed heavyweight in energy storage and renewable innovations, is tangled in a legal web over securities fraud. As of now, Fluence has been slapped with a class action lawsuit...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Safety Monitoring with LifeSphere Advanced Signals

Updated Category News Views 244

Revolutionizing Pharmacovigilance with AI In the realm of life sciences, ensuring patient safety is paramount. Recently, a prominent pharmaceutical organization announced its partnership with ArisGlobal in implementing the innovative LifeSphere Advanced Signals. This advanced pharmacovigilance solution utilizes automation and AI-driven insights to enhance signal detection...

Continue Reading
Arcellx Inc. Under Fire: Shareholder Concerns Mounting Fast

Updated Category News Views 163

What's Going Down with Arcellx? Kickin’ off with the news—Arcellx Inc. (NASDAQ: ACLX) is under the microscope for potential shareholder shenanigans. I mean, there’s chatter coming from the Ademi Firm, pointing fingers at the board for not playing fair with the shareholders. Not exactly a good look, right? This takes me back to times when I’ve seen boards pulling...

Continue Reading
Memecoins Rally: The Strategic Advantage of Investing in PEPE

Updated Category News Views 164

The Surge of Pepe and Shiba Inu in Recent Days In a surprising turn of events, the memecoins Pepe and Shiba Inu have experienced remarkable gains amidst a largely negative market atmosphere. While the broader cryptocurrency market has been facing some challenges, these two coins have struck a positive chord with traders and investors alike. Market Performance: Gains...

Continue Reading
Transforming the Electrical Grid: Lessons from Advanced Technologies

Updated Category News Views 176

Modernizing the Electrical Grid: An Urgent Need As the demand for energy continues to increase, the necessity for a robust and efficient electrical grid becomes increasingly evident. States across the nation are actively seeking solutions to modernize their utilities and ensure a reliable energy supply. One of the most promising approaches involves the implementation of...

Continue Reading
WEX Inc. CFO's Recent Stock Sale: Implications for Investors

Updated Category News Views 122

WEX Inc. CFO's Notable Stock Sale WEX Inc. (NYSE: WEX) Chief Financial Officer Jagtar Narula recently made headlines by selling 508 shares of the company's stock. Priced at $200 each, this sale totaled an impressive $101,600. Transactions of this magnitude naturally attract attention from both investors and market analysts. Context Behind the Sale The sale occurred under...

Continue Reading